Back to All Events

New Cancer Drugs and Why Optometrists Should Pay Attention

 
 

We will discuss 3 new classes of cancer drugs: antibody drug conjugates, checkpoint inhibitors and MEK inhibitors and how they affect the eyes

Almost 800 attended our event and we received amazing feedback!

Feedback from anonymous survey:

  • Love that she started with case studies/examples

  • Thank you Dr. it was a brand new topic for me, very informative!

  • Great topic with an interesting presentation.

  • Best lecture of the three in the ADC series

  • What a great lecture-well organized!

  • wonderful coverage of an important update thank you

  • Timely and excellent information

  • Speaker was super knowledgeable! Interesting topic.

  • Lots of new material

  • PHENOMENAL SPEAKER!!! AWESOME LECTURE!

  • Lots of new material

  • Dr. Canestraro presentation was engaging and easy to follow!!

  • Very interesting and helpful information since cancer is a growing problem and many people are taking these meds for treatment.


Speaker: Dr. Julia Canestraro

Thank you to ImmunoGen for supporting this event with unrestricted educational grant.

This event is COPE approved for 1 hour of continuing education credit.

Previous
Previous
January 13

The ABCs of ADCs

Next
Next
January 18

Woo U Cocktail Party